复星医药在深圳投资成立生物科技新公司

Group 1 - Recently, Fosun Kerry (Shenzhen) Biotechnology Co., Ltd. was established with a registered capital of 100 million yuan [1] - The legal representative of the new company is Chen Xingrong [1] - The business scope includes medical research and experimental development, cell technology research and application, human stem cell technology development and application, and human genetic diagnosis and treatment technology development [1] Group 2 - The company is wholly owned by Fosun Kerry (Shanghai) Biotechnology Co., Ltd., which is a subsidiary of Fosun Pharma [1]